Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 72162-1515

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide (NDC 72162-1515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721621515)

Label for Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide tablets, film-coated, strength 40 mg / 5 mg / 25 mg. The label shows the NDC 72162-1515-3, contains 30 tablets, is relabeled by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Par Pharmaceutical. Storage and usage instructions are partially visible on the left side.*

FDA Label Image

Olmesartan Medoxomil (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 1)

Chemical structure diagram of olmesartan medoxomil, showing the arrangement of atoms and functional groups in the molecule.*

FDA Label Image

Amlodipine Besylate (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 2)

Chemical structure diagram showing the molecular configuration related to olmesartan medoxomil, amlodipine besylate, or hydrochlorothiazide, corresponding to the active ingredients of the product olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide tablets. The image depicts detailed atomic bonds and groups characteristic of pharmaceutical compounds.*

FDA Label Image

Hydrochlorothiazide (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 3)

Chemical structure of olmesartan medoxomil, showing the molecular arrangement including sulfonamide and aromatic ring with chlorine substitution. The diagram depicts atoms and bonds characteristic of the compound.*

FDA Label Image

Figure 1 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 4)

A line graph displaying multiple data series plotted over a horizontal axis, with values ranging from 55 to 100 on the vertical axis. The chart includes baseline and four treatment group lines labeled with combinations of 40 mg, 10 mg, and HCTZ 25 mg doses, representing various formulations related to olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide.*

FDA Label Image

Figure 2 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 5)

A line graph titled 'Mean Ambulatory Systolic Blood Pressure at Endpoint by Treatment and Hour' showing mean systolic blood pressure (mmHg) on the vertical axis against hours post dose (0 to 24) on the horizontal axis. It compares baseline and four treatments: AML 10/HCTZ 25, OM40/AML10, OM40/HCTZ25, and OM40/AML10/HCTZ25 with different line styles and markers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.